1,1-dimethylurea has been researched along with Malaria in 1 studies
*Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, W; Mahmud, T; Roongsawang, N | 1 |
1 other study(ies) available for 1,1-dimethylurea and Malaria
| Article | Year |
|---|---|
Biosynthetic studies and genetic engineering of pactamycin analogs with improved selectivity toward malarial parasites.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Antimalarials; Gene Knockout Techniques; Gene Silencing; Genetic Engineering; HCT116 Cells; Humans; Malaria; Methylurea Compounds; Pactamycin; Plasmodium falciparum; Streptomyces; Transferases | 2011 |